Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Therapy01:28

Drug Therapy

327
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
327
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

402
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
402
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

269
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
269
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

4.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
4.6K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

232
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
232
Modified-Release Drug Delivery Systems: Influencing Factors01:20

Modified-Release Drug Delivery Systems: Influencing Factors

80
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
80

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Residual insulin secretion in long-standing type 1 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2025
Same author

Quantitative analysis of trabecular bone tissue cryosections via a fully automated neural network-based approach.

PloS one·2024
Same author

Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops.

Diabetologia·2023
Same author

Effect of High Hydrostatic Pressure on Human Trabecular Bone Regarding Cell Death and Matrix Integrity.

Frontiers in bioengineering and biotechnology·2021
Same author

Local Inflammatory Response after Intramuscularly Implantation of Anti-Adhesive Plasma-Fluorocarbon-Polymer Coated Ti6AI4V Discs in Rats.

Polymers·2021
Same author

Association of systemic antibody response against polyethylene terephthalate with inflammatory serum cytokine profile following implantation of differently coated vascular prostheses in a rat animal model.

Journal of biomedical materials research. Part A·2021

Related Experiment Videos

7 Strategies for Improving Drug Utilization.

Michael Schlosser, Ronald Chamberlain, Marcus Dortch

    Managed Care (Langhorne, Pa.)
    |June 30, 2017
    PubMed
    Summary

    New pharmaceutical products lack real-world data, causing challenges for healthcare payers and providers. This study explores strategies to resolve ambiguity beyond initial FDA approval efficacy and safety standards.

    Area of Science:

    • Health Economics and Outcomes Research
    • Pharmaceutical Policy

    Background:

    • New drugs often enter the market with limited real-world data.
    • Regulatory approval (e.g., FDA) typically relies on non-inferiority in efficacy and safety compared to existing treatments.
    • This data gap creates uncertainty for healthcare payers and providers regarding drug value and optimal use.

    Purpose of the Study:

    • To identify and evaluate promising strategies for addressing the ambiguity surrounding new pharmaceutical products.
    • To provide solutions for payers and providers facing decisions with limited real-world evidence.

    Main Methods:

    • Review of current approaches to post-market drug evaluation.
    • Analysis of emerging strategies for real-world evidence generation and utilization.
    • Case study examination of innovative payer and provider decision-making frameworks.
    Keywords:
    Viewpoint

    Related Experiment Videos

    Main Results:

    • Several strategies show potential for reducing ambiguity.
    • These strategies focus on enhancing real-world data collection and interpretation.
    • Effective implementation can improve value-based decision-making for new pharmaceuticals.

    Conclusions:

    • Addressing the real-world evidence gap is crucial for informed pharmaceutical adoption.
    • Proactive strategies can mitigate risks and optimize resource allocation for new drugs.
    • Further research and implementation of these strategies are recommended for healthcare systems.